Vivos Therapeutics Inc (NAS:VVOS)
$ 2.1 -0.07 (-3.23%) Market Cap: 6.78 Mil Enterprise Value: 6.27 Mil PE Ratio: 0 PB Ratio: 10.00 GF Score: 59/100

Vivos Therapeutics Inc at Emerging Growth Conference (Virtual) Transcript

Feb 22, 2023 / 05:35PM GMT
Release Date Price: $18.75 (+0.68%)
Ana Berry
Emerging Growth - Moderator

Welcome back, everyone. Next up, we have Vivos Therapeutics, Inc. It trades on the NASDAQ under the symbol VVOS, and is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities, such as mild to moderate obstructive sleep apnea and snoring in adults. The Vivos Method represents the first clinically effective nonsurgical, noninvasive non-pharmaceutical and cost-effective solution for treating mild to moderate OSA.

Happy to bring on the CEO, Kirk Huntsman. Thank you for joining us on our conference today, Kirk -- very excited to hear about this technology. And send it over to my father; he could really use this.

Kirk Huntsman
Vivos Therapeutics, Inc. - Chairman, Co-Founder, and CEO

All right, well, thank you, Ana. And I appreciate the opportunity to be here.

Ana Berry
Emerging Growth - Moderator

Great, take it

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot